Biggest News Aggregation in the World
📰 Label Study News

Page 3 - Label Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Label Study. Real-time updates on events, politics, business and more.

Revance Provides Corporate Update and Anticipated Milestones for 2021

Press release content from Business Wire. The AP news staff was not involved in its creation. Revance Provides Corporate Update and Anticipated Milestones for 2021 January 7, 2021 GMT NASHVILLE, Tenn.--(BUSINESS WIRE)--Jan 7, 2021-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today provided a corporate update, product pipeline timing and anticipated milestones for 2021. Financial Update and Key Launch Metrics: Pre...
United States Laurence Watts Jessica Serra Sara Fahy Nadine Tosk Mark Foley
Source: apnews.com

Cyclo Therapeutics Announces Positive Efficacy Data from Extension Protocol with Trappsol Cyclo in Patients with Niemann-Pick Disease Type C

Posted on 312 Cyclo Therapeutics, Inc. (NasdaqCM:CYTH) (NasdaqCM:CYTHW), a clinical stage biotechnology company developing a cyclodextrin platform for the treatment of neurodegenerative diseases, including its lead candidate Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C (NPC), today announced initial data from its “Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol ® Cyclo™ (HPBCD) ...
University Of Cincinnati United States Loren Pena Jeffreyl Tate Caroline Hastings Benny Liu

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science